Astek Diagnostics vs Digistain

<p>Astek Diagnostics offers the JIDDU platform, a clinical diagnostic software designed to confirm urinary tract infections (UTIs) and provide antibiotic sensitivity results in just one hour. This innovative tool drastically improves diagnostic speed and accuracy, helping you treat infections earlier and reduce patient complications and healthcare costs. The platform targets healthcare providers, enabling better clinical decision-making by eliminating guesswork in antibiotic prescriptions.</p> <p>With ongoing development to expand testing beyond urine to multiple sample types like CSF, effluent, and blood, Astek Diagnostics aims to create a universal diagnostic system. Partnering with reputable institutions, it focuses on reducing antibiotic resistance and improving patient outcomes by delivering rapid actionable results, making it a significant advancement in FemHealth and infection care.</p>

<p>Digistain is a sophisticated AI-enabled quantitative histopathology platform designed specifically for breast cancer risk stratification. It provides clinicians with fast, clear, and easy-to-interpret results, enabling personalized treatment planning for invasive breast cancer patients. By integrating seamlessly into existing histopathology workflows and operating on routine tissue samples, Digistain delivers risk assessments within an hour, significantly reducing wait times compared to traditional methods. </p> <p>You can rely on Digistain to help reduce treatment decision times and lower costs, making advanced recurrence risk prediction more accessible. Its technology captures detailed biopsy data and employs artificial intelligence to generate a precise prognostic score, supporting multidisciplinary team discussions without replacing clinical judgment.</p>